Stefan K.f. Schwabe is President & CMO +1 at SUPERNUS PHARMACEUTICALS, INC. (SUPN). They have made 4 open-market trades across 1 company since 2015, most recently 2020-12-21.
CIK 0001557657
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SUPN | 2,772 | $105K |
Shares reported on the most recent Form 4, priced at the 2020-12-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SUPN | SELL | 2020-12-21 | 2020-12-22 | $22.10 | $2.0M | -1.6% | +7.8% | +3.8% |
| SUPN | SELL | 2020-12-14 | 2020-12-15 | $21.87 | $1.2M | +15.3% | +32.6% | +23.4% |
| SUPN | SELL | 2018-06-18 | 2018-06-19 | $54.39 | $3.3M | +7.5% | -2.6% | -17.4% |
| SUPN | SELL | 2017-09-07 | 2017-09-11 | $46.59 | $4.4M | -18.4% | -14.7% | -21.4% |
| SUPN | SELL · 10b5-1 | 2015-07-28 | 2015-07-29 | $21.20 | $50K | -17.4% | -0.2% | -0.2% |
| SUPN | SELL · 10b5-1 | 2015-07-13 | 2015-07-29 | $19.23 | $37K | -17.4% | -0.2% | -0.2% |
| SUPN | SELL · 10b5-1 | 2015-06-12 | 2015-06-15 | $18.27 | $37K | -17.4% | -0.2% | -0.2% |
| SUPN | SELL · 10b5-1 | 2015-06-11 | 2015-06-12 | $16.40 | $60K | -17.4% | -0.2% | -0.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.